Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 444-452, April 2010

Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review

  • Panagiotis Peitsidis

      Affiliations

    • The Royal Free and University College Medical School, University College London, Gower Street, London, UK
    • Both authors contributed equally to this review.
    • ,
  • Rina Agrawal

      Affiliations

    • University College London, Gower Street, London, UK
    • Corresponding Author InformationCorresponding author.
    • Both authors contributed equally to this review.

Received 23 June 2009; received in revised form 11 August 2009; accepted 3 December 2009. published online 16 February 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

Abstract 

The aim of this study was to investigate the strategic role of vascular endothelial growth factor (VEGF) in the pathophysiology of polycystic ovary syndrome (PCOS) and to critically review the published trials that have evaluated VEGF in women with PCOS. An electronic database search of Medline, Embase, Cinahl and Cochrane library was conducted. Studies were included if they evaluated VEGF either in the circulation or in granulosa lutein cell culture media in in-vitro laboratory studies of women with a polycystic ovary (PCO) or PCOS. Studies analysing immunohistochemical expression of VEGF in PCO were also included. This review concluded that VEGF may have a strategic role in the pathophysiology of PCOS and is the key mediator in the pathogenesis of ovarian hyperstimulation syndrome (OHSS) in women undergoing assisted reproductive procedures. Its role is perhaps not singular and several other factors such as the bioavailability of its soluble receptor sFlt-1 and a multidisciplinary orchestration of other cytokines and growth factors may be involved in the pathophysiology of PCOS and OHSS.

Keywords: OHSS, PCO, PCOS, VEGF

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Panagiotis Peitsidis MD, PhD completed his training in Obstetrics and Gynaecology in Athens, Greece. Since 2008, he has been working as a Clinical Research Fellow in the department of Obstetrics and Gynaecology at The Royal Free Hospital in London, UK. His research interests include fetal medicine, ultrasound, colposcopy, and gynecological oncology. He is a referee for several medical journals and has published extensively. He recently received his PhD from the University of Athens on prognostic factors in patients with Fallopian tube cancer.

PII: S1472-6483(10)00009-X

doi:10.1016/j.rbmo.2010.01.007

Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 444-452, April 2010

Article Tools

* Image Usage & Resolution